Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and ...
SHANGHAI/SUZHOU, China, April 19 (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA ...
China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the ...
China's Drugmakers Can't Sell MRNA Shots but Haven't Quit Yet By Andrew Silver SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle ...
SHANGHAI/SUZHOU, China (Reuters) – China’s vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they ...
A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. Corner Therapeutics’ Series A round was led by Ziff ...
A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. Corner Therapeutics’ Series A round was led by Ziff ...
SHANGHAI/SUZHOU, China (Reuters) - China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology ...
Australia's vaccination program saved the lives of almost 20,000 people in New South Wales alone between August 2021 and July 2022, according to new research. (Luis Enrique Ascui/The Age ...
The team used a simulation of NSW's vaccination and COVID-19 death rates in people aged 50 or older to see how vaccination and how second and third doses impacted COVID-19 deaths, and predict what ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback